Optimization of 89Zr production using Monte Carlo simulations

被引:0
作者
Abdulrahman Alfuraih
Khalid Alzimami
Andy K. Ma
Ali Alghamdi
机构
[1] King Saud University,Department of Radiological Sciences
[2] University of Dammam,Department of Radiological Sciences
来源
Journal of Radioanalytical and Nuclear Chemistry | 2013年 / 296卷
关键词
Monte Carlo simulations; Immuno-PET;
D O I
暂无
中图分类号
学科分类号
摘要
Zirconium-89 (89Zr) can be produced in a cyclotron by focusing the proton beam on an yttrium-89 (89Y) foil target. Optimal combination of beam energy and target assembly configuration enables maximum production of 89Zr while minimizing the formation of contaminant nuclides such as 88Zr and 88Y to allow efficient and effective radiopharmaceutical labeling. Accurate modeling of the proton beam and the target is therefore an essential step to assure the best beam and target specification. We used the radiation transport code MCNPX to simulate the transport of protons through the irradiation assembly and the nuclear reaction code TALYS to obtain the production cross sections of various nuclides from proton-89Y reactions. Results from simulating the irradiation of 14 mm diameter targets with aluminum (Al) degrader at 19.8 mA for 1 h suggested that the 0.15 mm thick one would produce 227 MBq while the 0.3 mm thick one would produce 413 MBq of 89Zr with less than 1 % uncertainty. These results show excellent agreement with experimental work in literature. This work provides the basis for further experimental and theoretical assessments of the use of 89Zr as radiopharmaceutical labels.
引用
收藏
页码:1025 / 1029
页数:4
相关论文
共 56 条
[1]  
Aerts HJWL(2009)Disparity between in vivo EGFR expression and J Nucl Med 50 123-131
[2]  
Dubois L(2009)Zr-labeled cetuximab uptake assessed with PET J Nucl Med 50 1828-1836
[3]  
Perk L(1997)Radiation dosimetry of J Nucl Med 38 112-118
[4]  
Vermaelen P(2006)Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients Eur J Nucl Med Mol Imaging 33 1337-1345
[5]  
van van Dongen GaMS(2003)Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice J Nucl Med 44 1271-1281
[6]  
Wouters BG(2010)Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography Nucl Med Biol 36 729-739
[7]  
Lambin P(1990)Zr immuno-PET: comprehensive procedures for the production of Int J Radiat Appl Instrum Part A Appl Radiat Isot 41 789-790
[8]  
Börjesson PKE(2011)Zr-labeled monoclonal antibodies Appl Radiat Isot 69 1134-1137
[9]  
Jauw YWS(2011)Standardized methods for the production of high specific-activity zirconium-89 Radiochim Acta 99 631-634
[10]  
de Bree R(undefined)Production and purification of undefined undefined undefined-undefined